Léa Chantal Tran
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Léa Chantal Tran has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
Delphine Ley
Univ. Lille, Inserm, CHU Lille, U1286—INFINITE—Institute for Translational Research in Inflammation, Lille, France
3 shared publicationsEdwina Micours
Univ. Lille, Inserm, CHU Lille, U1286—INFINITE—Institute for Translational Research in Inflammation, Lille, France
3 shared publicationsFrédéric Gottrand
Univ. Lille, Inserm, CHU Lille, U1286—INFINITE—Institute for Translational Research in Inflammation, Lille, France
3 shared publications- Frédéric Gottrand
Lille University, France
3 shared publications - Jean Lesage
Univ. Lille, Inserm, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, F-59000 Lille, France
3 shared publications - Lucie Marousez
Univ. Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation , Lille F-59000
3 shared publications
Latest Publications
- 7 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Les facteurs bioactifs du lait maternel : de leur préservation lors du traitement du lait à l'impact de la lactoferrine sur la maturation intestinale
La période néonatale correspond à une phase intense du développement de l'intestin durant laquelle se met en place la barrière intestinale. Des données suggèrent que l'environnement nutritionnel précoce joue un rôle critique dans ce processus et programme également la santé future digestive de l'enfant. Chez la souris, le retard de croissance post-natal (RCPN) est associé à un retard de maturation de l'intestin et à une susceptibilité accrue à développer une colite à l'âge adulte. Chez l'Homme, l'allaitement maternel est particulièrement protecteur pour la survenue de pathologies digestives chez l'enfant. Ces effets bénéfiques du lait maternel sont attribués à sa richesse en facteurs bioactifs, tels que des hormones, des agents immunomodulateurs ou encore la lactoferrine, une protéine abondante du lait possédant des activités antimicrobienne, anti-inflammatoire et prébiotique. En clinique, les enfants prématurés ou présentant un RCPN sont fréquemment alimentés par du lait maternel de mères donneuses collecté par les lactariums. Dans ces structures, le lait maternel est stérilisé par la pasteurisation de Holder (HoP) bien que celle-ci altère de nombreux facteurs bioactifs par son effet thermique. Une alternative à la HoP pourrait être l'usage d'une stérilisation non thermique par haute pression hydrostatique (HHP).Dans ce contexte, les objectifs de ce travail ont été : 1) de caractériser l'impact d'une supplémentation orale durant la lactation en lactoferrine bovine (bLf), sur la maturation intestinale de souriceaux RCPN et, 2) d'évaluer l'usage de la HHP comparativement à la HoP sur la préservation de certains facteurs bioactifs du lait maternel humain.Chez des souriceaux, un RCPN a été induit par augmentation du nombre de petits par portée. Il a conduit à un retard de maturation intestinale au sevrage, associant une diminution de la profondeur des cryptes iléales, une surexpression de la lactase et un enrichissement du microbiote intestinal en Lactobacillales. Une importante altération du transcriptome intestinal par le RCPN a été observée notamment pour des gènes de l'horloge circadienne avec une surexpression des gènes Per2, Per3, Tef et Usp2, et une sous-expression de Bmal1 et Rev-erbα. La supplémentation en bLf pendant la lactation n'a pas modifié ces altérations intestinales mais elle a réduit la richesse du microbiote des souriceaux contrôles en modulant sa composition en Bacteroidales, Gammaproteobacteria et Clostridia. Enfin, la sévérité de la colite aiguë induite après le sevrage n'était pas différente entre les différents groupes expérimentaux.Concernant la préservation des facteurs bioactifs du lait après stérilisation, nous avons montré que la technique de HHP préservait mieux les hormones du lait, comme l'insuline, la leptine, le cortisol, l'apéline, le GLP-1 et la nesfatine-1, comparativement à la HoP bien que, pour l'adiponectine, ce traitement réduit son taux comparativement à la HoP. La HHP préservait également mieux la lactoferrine, par rapport à la HoP alors que le lysozyme, n'était pas affecté par ces deux traitements. L'évaluation de l'activité antimicrobienne des laits traités par HHP sur la croissance bactérienne au cours du temps a montré un fort effet bactériostatique contre Escherichia coli ainsi qu'un effet bactéricide plus important contre Streptococcus agalactiae, comparativement au lait traité par HoP.Au final, nos travaux démontrent l'importance d'une maturation intestinale adéquate pendant la période postnatale précoce et renforce l'intérêt des facteurs bioactifs du lait maternel dans la prévention des conséquences délétères du retard de maturation intestinale. Ils renforcent aussi l'importance de leur préservation par des traitements appropriés dans le cadre de la stérilisation des dons de lait au sein des lactariums.
- 7 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Les facteurs bioactifs du lait maternel : de leur préservation lors du traitement du lait à l'impact de la lactoferrine sur la maturation intestinale
La période néonatale correspond à une phase intense du développement de l'intestin durant laquelle se met en place la barrière intestinale. Des données suggèrent que l'environnement nutritionnel précoce joue un rôle critique dans ce processus et programme également la santé future digestive de l'enfant. Chez la souris, le retard de croissance post-natal (RCPN) est associé à un retard de maturation de l'intestin et à une susceptibilité accrue à développer une colite à l'âge adulte. Chez l'Homme, l'allaitement maternel est particulièrement protecteur pour la survenue de pathologies digestives chez l'enfant. Ces effets bénéfiques du lait maternel sont attribués à sa richesse en facteurs bioactifs, tels que des hormones, des agents immunomodulateurs ou encore la lactoferrine, une protéine abondante du lait possédant des activités antimicrobienne, anti-inflammatoire et prébiotique. En clinique, les enfants prématurés ou présentant un RCPN sont fréquemment alimentés par du lait maternel de mères donneuses collecté par les lactariums. Dans ces structures, le lait maternel est stérilisé par la pasteurisation de Holder (HoP) bien que celle-ci altère de nombreux facteurs bioactifs par son effet thermique. Une alternative à la HoP pourrait être l'usage d'une stérilisation non thermique par haute pression hydrostatique (HHP).Dans ce contexte, les objectifs de ce travail ont été : 1) de caractériser l'impact d'une supplémentation orale durant la lactation en lactoferrine bovine (bLf), sur la maturation intestinale de souriceaux RCPN et, 2) d'évaluer l'usage de la HHP comparativement à la HoP sur la préservation de certains facteurs bioactifs du lait maternel humain.Chez des souriceaux, un RCPN a été induit par augmentation du nombre de petits par portée. Il a conduit à un retard de maturation intestinale au sevrage, associant une diminution de la profondeur des cryptes iléales, une surexpression de la lactase et un enrichissement du microbiote intestinal en Lactobacillales. Une importante altération du transcriptome intestinal par le RCPN a été observée notamment pour des gènes de l'horloge circadienne avec une surexpression des gènes Per2, Per3, Tef et Usp2, et une sous-expression de Bmal1 et Rev-erbα. La supplémentation en bLf pendant la lactation n'a pas modifié ces altérations intestinales mais elle a réduit la richesse du microbiote des souriceaux contrôles en modulant sa composition en Bacteroidales, Gammaproteobacteria et Clostridia. Enfin, la sévérité de la colite aiguë induite après le sevrage n'était pas différente entre les différents groupes expérimentaux.Concernant la préservation des facteurs bioactifs du lait après stérilisation, nous avons montré que la technique de HHP préservait mieux les hormones du lait, comme l'insuline, la leptine, le cortisol, l'apéline, le GLP-1 et la nesfatine-1, comparativement à la HoP bien que, pour l'adiponectine, ce traitement réduit son taux comparativement à la HoP. La HHP préservait également mieux la lactoferrine, par rapport à la HoP alors que le lysozyme, n'était pas affecté par ces deux traitements. L'évaluation de l'activité antimicrobienne des laits traités par HHP sur la croissance bactérienne au cours du temps a montré un fort effet bactériostatique contre Escherichia coli ainsi qu'un effet bactéricide plus important contre Streptococcus agalactiae, comparativement au lait traité par HoP.Au final, nos travaux démontrent l'importance d'une maturation intestinale adéquate pendant la période postnatale précoce et renforce l'intérêt des facteurs bioactifs du lait maternel dans la prévention des conséquences délétères du retard de maturation intestinale. Ils renforcent aussi l'importance de leur préservation par des traitements appropriés dans le cadre de la stérilisation des dons de lait au sein des lactariums.
- 11 November 2025
- Published by Springer Nature in Pediatric Research
- Vol. 99 (7) , 1-10
Early growth restriction disrupts mice intestinal clock and homeostasis without being prevented by lactoferrin
Background Preterm infants and growth-restricted newborns are highly susceptible to intestinal inflammation and sepsis. We studied the effects of oral supplementation with bovine lactoferrin (bLf) during lactation in postnatal growth-restricted (PNGR) mice on intestinal development and susceptibility to colitis at weaning. Methods Growth restriction was induced in FVB/NRj mice from large litters from postnatal day (PN) 4 to 21. bLf (300 mg/kg/d) was administered from PN8 to PN21. Intestinal function was evaluated at PN21 by morphology, RNA sequencing, microbiota composition, and cecal short chain fatty acid levels. At PN22, acute colitis was induced by 3% dextran sulfate sodium (DSS). Colitis severity was assessed at PN29 histologically and RT-qPCR. Results PNGR altered the expression of genes related to circadian rhythm in intestines but did not increase susceptibility to DSS-induced acute colitis post weaning. PNGR-induced growth retardation and intestinal immaturity were not improved by bLf supplementation. bLf supplementation affected the microbiota composition in control, but not PNGR pups, and slightly reduced the inflammatory effects of colitis in PNGR. Conclusion PNGR alters intestinal development by affecting the intestinal transcriptome during lactation. bLf supplementation does not prevent growth restriction effects on gut health but could modulate gut microbiota in control pups during this period. Impact Postnatal growth restriction induces changes in the intestinal transcriptome with a disruption of clock-related gene expression. Postnatal growth restriction alters intestinal microbiota composition but does not amplify the response to an inflammatory-induced acute colitis after weaning. Bovine lactoferrin supplementation does not improve an induced growth restriction and its altered intestinal barrier structure. Bovine lactoferrin supplementation may induce positive intestinal microbial changes especially in control mice during lactation.
- 11 November 2025
- Published by Springer Nature in Pediatric Research
- Vol. 99 (7) , 1-10
Early growth restriction disrupts mice intestinal clock and homeostasis without being prevented by lactoferrin
Background Preterm infants and growth-restricted newborns are highly susceptible to intestinal inflammation and sepsis. We studied the effects of oral supplementation with bovine lactoferrin (bLf) during lactation in postnatal growth-restricted (PNGR) mice on intestinal development and susceptibility to colitis at weaning. Methods Growth restriction was induced in FVB/NRj mice from large litters from postnatal day (PN) 4 to 21. bLf (300 mg/kg/d) was administered from PN8 to PN21. Intestinal function was evaluated at PN21 by morphology, RNA sequencing, microbiota composition, and cecal short chain fatty acid levels. At PN22, acute colitis was induced by 3% dextran sulfate sodium (DSS). Colitis severity was assessed at PN29 histologically and RT-qPCR. Results PNGR altered the expression of genes related to circadian rhythm in intestines but did not increase susceptibility to DSS-induced acute colitis post weaning. PNGR-induced growth retardation and intestinal immaturity were not improved by bLf supplementation. bLf supplementation affected the microbiota composition in control, but not PNGR pups, and slightly reduced the inflammatory effects of colitis in PNGR. Conclusion PNGR alters intestinal development by affecting the intestinal transcriptome during lactation. bLf supplementation does not prevent growth restriction effects on gut health but could modulate gut microbiota in control pups during this period. Impact Postnatal growth restriction induces changes in the intestinal transcriptome with a disruption of clock-related gene expression. Postnatal growth restriction alters intestinal microbiota composition but does not amplify the response to an inflammatory-induced acute colitis after weaning. Bovine lactoferrin supplementation does not improve an induced growth restriction and its altered intestinal barrier structure. Bovine lactoferrin supplementation may induce positive intestinal microbial changes especially in control mice during lactation.
- Open Access
- 7 June 2025
- Published by Springer Nature in Pediatric Research
- p. 1-9
A nationwide experience of biological treatments in children with eosinophilic esophagitis
Background: No biological treatment has been approved for pediatric eosinophilic esophagitis (EoE) in France. For patients refractory to conventional treatments, although compassionate use of monoclonal antibodies has developed, experience remains limited. Methods: We conducted a national multicenter study across French pediatric tertiary care centers where children (younger than 18 years) who presented with EoE were treated with biological therapies between January 2015 and December 2023. The main objective was to characterize this patient population, and the indications for prescribing biologics. The secondary goals were to assess these patients’ clinical, endoscopic, and histologic finding, as well as patient tolerance, and to compare our cohort at baseline with pediatric patients from two European registers of EoE treated with conventional therapies. Results: Thirty-six patients were prescribed 37 biologics (omalizumab, n = 1; mepolizumab, n = 6; dupilumab, n = 30). At diagnosis, the mean patient age was 7.4 (±4.4) years, and most patients had at least one atopic comorbidity (91.7%, n = 33). Failure of first-line treatments was the main reason for starting biological therapy (75.7%, n = 28), prescribed as compassionate use (54.1%, n = 20). Dupilumab showed significant clinical (48%, p < 0.01) and histological (82.6%, p < 0.01) improvement. Compared with children treated with conventional therapies, patients in our cohort at baseline presented significantly more asthma, food allergies, and atopic dermatitis, as well as more fibrostenotic phenotype and digestive symptoms. No severe side effect was reported within a 6–12-month follow-up. Conclusion: Dupilumab is the most frequently prescribed, and appears to be the most effective biotherapy, regarding clinical and histologic remission. All biologics were well-tolerated. Impact: Pending marketing authorization, biological therapies for pediatric eosinophilic esophagitis are mainly prescribed after failure of first-line treatments and on a compassionate basis in France. Dupilumab is the biotherapy most frequently used, is associated with clinical and histological efficacy and is well-tolerated. Children and adolescents requiring biologics appear to be younger and more severe at diagnosis than naive pediatric patients in Europeans registries.
- 7 June 2025
- Published by Springer Nature in Pediatric Research
- p. 1-9
Open AccessA nationwide experience of biological treatments in children with eosinophilic esophagitis
Background: No biological treatment has been approved for pediatric eosinophilic esophagitis (EoE) in France. For patients refractory to conventional treatments, although compassionate use of monoclonal antibodies has developed, experience remains limited. Methods: We conducted a national multicenter study across French pediatric tertiary care centers where children (younger than 18 years) who presented with EoE were treated with biological therapies between January 2015 and December 2023. The main objective was to characterize this patient population, and the indications for prescribing biologics. The secondary goals were to assess these patients’ clinical, endoscopic, and histologic finding, as well as patient tolerance, and to compare our cohort at baseline with pediatric patients from two European registers of EoE treated with conventional therapies. Results: Thirty-six patients were prescribed 37 biologics (omalizumab, n = 1; mepolizumab, n = 6; dupilumab, n = 30). At diagnosis, the mean patient age was 7.4 (±4.4) years, and most patients had at least one atopic comorbidity (91.7%, n = 33). Failure of first-line treatments was the main reason for starting biological therapy (75.7%, n = 28), prescribed as compassionate use (54.1%, n = 20). Dupilumab showed significant clinical (48%, p < 0.01) and histological (82.6%, p < 0.01) improvement. Compared with children treated with conventional therapies, patients in our cohort at baseline presented significantly more asthma, food allergies, and atopic dermatitis, as well as more fibrostenotic phenotype and digestive symptoms. No severe side effect was reported within a 6–12-month follow-up. Conclusion: Dupilumab is the most frequently prescribed, and appears to be the most effective biotherapy, regarding clinical and histologic remission. All biologics were well-tolerated. Impact: Pending marketing authorization, biological therapies for pediatric eosinophilic esophagitis are mainly prescribed after failure of first-line treatments and on a compassionate basis in France. Dupilumab is the biotherapy most frequently used, is associated with clinical and histological efficacy and is well-tolerated. Children and adolescents requiring biologics appear to be younger and more severe at diagnosis than naive pediatric patients in Europeans registries.
- 27 January 2024
- Published by Springer Nature in Pediatric Research
- Vol. 95 (7) , 1749-1753
High hydrostatic pressure is similar to Holder pasteurization in preserving donor milk antimicrobial activity
Background The microbiological safety of donor milk (DM) is commonly ensured by Holder pasteurization (HoP, 62.5 °C for 30 min) in human milk banks despite its detrimental effects on bioactive factors. We compared the antimicrobial properties of DM after Holder pasteurization treatment or High Hydrostatic Pressure processing (HHP, 350 MPa at 38 °C), a non-thermal substitute for DM sterilization. Methods We assessed lactoferrin and lysozyme concentrations in raw, HHP- and HoP-treated pools of DM (n = 8). The impact of both treatments was evaluated on the growth of Escherichia coli and Group B Streptococcus in comparison with control media (n = 4). We also addressed the effect of storage of HHP treated DM over a 6-month period (n = 15). Results HHP milk demonstrated similar concentrations of lactoferrin compared with raw milk, while it was significantly decreased by HoP. Lysozyme concentrations remained stable regardless of the condition. Although a bacteriostatic effect was observed against Escherichia coli at early timepoints, a sharp bactericidal effect was observed against Group B Streptococcus. Unlike HoP, these results were significant for HHP compared to controls. Stored DM was well and safely preserved by HHP. Conclusion Our study demonstrates that this alternative sterilization method shows promise for use with DM in human milk banks. Impact Antimicrobial activity of donor milk after High Hydrostatic Pressure treatment has not been clearly evaluated. Donor milk lactoferrin is better preserved by High Hydrostatic Pressure than conventional Holder pasteurization, while lysozyme concentration is not affected by either treatment. As with Holder pasteurization, High Hydrostatic Pressure preserves donor milk bacteriostatic activity against E. coli in addition to bactericidal activity against Group B Streptococcus. Donor milk treated by High Hydrostatic Pressure can be stored safely for 6 months.
- 27 January 2024
- Published by Springer Nature in Pediatric Research
- Vol. 95 (7) , 1749-1753
High hydrostatic pressure is similar to Holder pasteurization in preserving donor milk antimicrobial activity
Background The microbiological safety of donor milk (DM) is commonly ensured by Holder pasteurization (HoP, 62.5 °C for 30 min) in human milk banks despite its detrimental effects on bioactive factors. We compared the antimicrobial properties of DM after Holder pasteurization treatment or High Hydrostatic Pressure processing (HHP, 350 MPa at 38 °C), a non-thermal substitute for DM sterilization. Methods We assessed lactoferrin and lysozyme concentrations in raw, HHP- and HoP-treated pools of DM (n = 8). The impact of both treatments was evaluated on the growth of Escherichia coli and Group B Streptococcus in comparison with control media (n = 4). We also addressed the effect of storage of HHP treated DM over a 6-month period (n = 15). Results HHP milk demonstrated similar concentrations of lactoferrin compared with raw milk, while it was significantly decreased by HoP. Lysozyme concentrations remained stable regardless of the condition. Although a bacteriostatic effect was observed against Escherichia coli at early timepoints, a sharp bactericidal effect was observed against Group B Streptococcus. Unlike HoP, these results were significant for HHP compared to controls. Stored DM was well and safely preserved by HHP. Conclusion Our study demonstrates that this alternative sterilization method shows promise for use with DM in human milk banks. Impact Antimicrobial activity of donor milk after High Hydrostatic Pressure treatment has not been clearly evaluated. Donor milk lactoferrin is better preserved by High Hydrostatic Pressure than conventional Holder pasteurization, while lysozyme concentration is not affected by either treatment. As with Holder pasteurization, High Hydrostatic Pressure preserves donor milk bacteriostatic activity against E. coli in addition to bactericidal activity against Group B Streptococcus. Donor milk treated by High Hydrostatic Pressure can be stored safely for 6 months.
- Open Access
The Sterilization of Human Milk by Holder Pasteurization or by High Hydrostatic Pressure Processing Leads to Differential Intestinal Effects in Mice
Background: Human milk banks (HMBs) provide sterilized donor milk (DM) for the feeding of preterm infants. Most HMBs use the standard method of Holder pasteurization (HoP) performed by heating DM at 62.5 °C for 30 min. High hydrostatic pressure (HHP) processing has been proposed as an alternative to HoP. This study aims to evaluate intestinal barrier integrity and microbiota composition in adult mice subjected to a chronic oral administration of HoP- or HHP-DM. Methods: Mice were treated by daily gavages with HoP- or HHP-DM over seven days. Intestinal barrier integrity was assessed through in vivo 4 kDa FITC–dextran permeability assay and mRNA expression of several tight junctions and mucins in ileum and colon. Cecal short chain fatty acids (SCFAs) and microbiota were analyzed. Results: HHP-DM mice displayed decreased intestinal permeability to FITC–dextran and increased ileal mRNA expression levels of two tight junctions (Ocln and Cdh1) and Muc2. In the colon, mRNA expression levels of two tight junctions (Cdh1 and Tjp1) and of two mucins (Muc2 and Muc4) were decreased in HHP-DM mice. Cecal SCFAs and microbiota were not different between groups. Conclusions: HHP processing of DM reinforces intestinal barrier integrity in vivo without affecting gut microbiota and SCFAs production. This study reinforces previous findings showing that DM sterilization through HHP might be beneficial for the intestinal maturation of preterm infants compared with the use of HoP for the treatment of DM.
Open AccessThe Sterilization of Human Milk by Holder Pasteurization or by High Hydrostatic Pressure Processing Leads to Differential Intestinal Effects in Mice
Background: Human milk banks (HMBs) provide sterilized donor milk (DM) for the feeding of preterm infants. Most HMBs use the standard method of Holder pasteurization (HoP) performed by heating DM at 62.5 °C for 30 min. High hydrostatic pressure (HHP) processing has been proposed as an alternative to HoP. This study aims to evaluate intestinal barrier integrity and microbiota composition in adult mice subjected to a chronic oral administration of HoP- or HHP-DM. Methods: Mice were treated by daily gavages with HoP- or HHP-DM over seven days. Intestinal barrier integrity was assessed through in vivo 4 kDa FITC–dextran permeability assay and mRNA expression of several tight junctions and mucins in ileum and colon. Cecal short chain fatty acids (SCFAs) and microbiota were analyzed. Results: HHP-DM mice displayed decreased intestinal permeability to FITC–dextran and increased ileal mRNA expression levels of two tight junctions (Ocln and Cdh1) and Muc2. In the colon, mRNA expression levels of two tight junctions (Cdh1 and Tjp1) and of two mucins (Muc2 and Muc4) were decreased in HHP-DM mice. Cecal SCFAs and microbiota were not different between groups. Conclusions: HHP processing of DM reinforces intestinal barrier integrity in vivo without affecting gut microbiota and SCFAs production. This study reinforces previous findings showing that DM sterilization through HHP might be beneficial for the intestinal maturation of preterm infants compared with the use of HoP for the treatment of DM.
- Open Access
Prebiotic Supplementation during Lactation Affects Microbial Colonization in Postnatal-Growth-Restricted Mice
Background: An inadequate perinatal nutritional environment can alter the maturation of the intestinal barrier and promote long-term pathologies such as metabolic syndrome or chronic intestinal diseases. The intestinal microbiota seems to play a determining role in the development of the intestinal barrier. In the present study, we investigated the impact of consuming an early postnatal prebiotic fiber (PF) on growth, intestinal morphology and the microbiota at weaning in postnatal-growth-restricted mice (PNGR). Methods: Large litters (15 pups/mother) were generated from FVB/NRj mice to induce PNGR at postnatal day 4 (PN4) and compared to control litters (CTRL, 8 pups/mother). PF (a resistant dextrin) or water was orally administered once daily to the pups from PN8 to PN20 (3.5 g/kg/day). Intestinal morphology was evaluated at weaning (PN21) using the ileum and colon. Microbial colonization and short-chain fatty acid (SCFA) production were investigated using fecal and cecal contents. Results: At weaning, the PNGR mice showed decreased body weight and ileal crypt depth compared to the CTRL. The PNGR microbiota was associated with decreased proportions of the Lachnospiraceae and Oscillospiraceae families and the presence of the Akkermansia family and Enterococcus genus compared to the CTRL pups. The propionate concentrations were also increased with PNGR. While PF supplementation did not impact intestinal morphology in the PNGR pups, the proportions of the Bacteroides and Parabacteroides genera were enriched, but the proportion of the Proteobacteria phylum was reduced. In the CTRL pups, the Akkermansia genus (Verrucomicrobiota phylum) was present in the PF-supplemented CTRL pups compared to the water-supplemented ones. Conclusions: PNGR alters intestinal crypt maturation in the ileum at weaning and gut microbiota colonization. Our data support the notion that PF supplementation might improve gut microbiota establishment during the early postnatal period.
Open AccessPrebiotic Supplementation during Lactation Affects Microbial Colonization in Postnatal-Growth-Restricted Mice
Background: An inadequate perinatal nutritional environment can alter the maturation of the intestinal barrier and promote long-term pathologies such as metabolic syndrome or chronic intestinal diseases. The intestinal microbiota seems to play a determining role in the development of the intestinal barrier. In the present study, we investigated the impact of consuming an early postnatal prebiotic fiber (PF) on growth, intestinal morphology and the microbiota at weaning in postnatal-growth-restricted mice (PNGR). Methods: Large litters (15 pups/mother) were generated from FVB/NRj mice to induce PNGR at postnatal day 4 (PN4) and compared to control litters (CTRL, 8 pups/mother). PF (a resistant dextrin) or water was orally administered once daily to the pups from PN8 to PN20 (3.5 g/kg/day). Intestinal morphology was evaluated at weaning (PN21) using the ileum and colon. Microbial colonization and short-chain fatty acid (SCFA) production were investigated using fecal and cecal contents. Results: At weaning, the PNGR mice showed decreased body weight and ileal crypt depth compared to the CTRL. The PNGR microbiota was associated with decreased proportions of the Lachnospiraceae and Oscillospiraceae families and the presence of the Akkermansia family and Enterococcus genus compared to the CTRL pups. The propionate concentrations were also increased with PNGR. While PF supplementation did not impact intestinal morphology in the PNGR pups, the proportions of the Bacteroides and Parabacteroides genera were enriched, but the proportion of the Proteobacteria phylum was reduced. In the CTRL pups, the Akkermansia genus (Verrucomicrobiota phylum) was present in the PF-supplemented CTRL pups compared to the water-supplemented ones. Conclusions: PNGR alters intestinal crypt maturation in the ileum at weaning and gut microbiota colonization. Our data support the notion that PF supplementation might improve gut microbiota establishment during the early postnatal period.
- 16 July 2022
- Published by Elsevier in The Journal of Pediatrics
- Vol. 251, 134-139.e2
Comparison of Endoscopic Dilatation and Heller's Myotomy for Treating Esophageal Achalasia in Children: A Multicenter Study
- 16 July 2022
- Published by Elsevier in The Journal of Pediatrics
- Vol. 251, 134-139.e2
Comparison of Endoscopic Dilatation and Heller's Myotomy for Treating Esophageal Achalasia in Children: A Multicenter Study
- 1 January 2022
- Published by Elsevier in Clinical Nutrition
- Vol. 41 (1) , 1-8
High hydrostatic pressure processing of human milk preserves milk oligosaccharides and avoids formation of Maillard reaction products
- 1 January 2022
- Published by Elsevier in Clinical Nutrition
- Vol. 41 (1) , 1-8
High hydrostatic pressure processing of human milk preserves milk oligosaccharides and avoids formation of Maillard reaction products
- 1 March 2017
- Published by Elsevier in Archives de Pédiatrie
- Vol. 24 (3) , 211-214
Vaccination antigrippale de l’enfant : vaccins inactivés ou vivants atténués ?
- 1 March 2017
- Published by Elsevier in Archives de Pédiatrie
- Vol. 24 (3) , 211-214
Vaccination antigrippale de l’enfant : vaccins inactivés ou vivants atténués ?